GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of AZNCF
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

AstraZeneca PLC stock downgraded to Hold/Accumulate
(Updated on Apr 18, 2024)

Buy or Hold candidate since Apr 17, 2024 Loss -1.36% PDF

The AstraZeneca PLC stock price fell by -1.36% on the last day (Thursday, 18th Apr 2024) from $140.15 to $138.24. During the last trading day the stock fluctuated 3.78% from a day low at $133.20 to a day high of $138.24. The price has been going up and down for this period, and there has been a 0.65% gain for the last 2 weeks. Volume has increased on the last day by 526 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 752 shares were bought and sold for approximately $103.96 thousand.

The stock lies in the upper part of a wide and weak rising trend in the short term, and this may normally pose a very good selling opportunity for the short-term trader as reaction back towards the lower part of the trend can be expected. A break-up at the top trend line at $140.26 will firstly indicate a stronger rate of rising. Given the current short-term trend, the stock is expected to rise 5.28% during the next 3 months and, with a 90% probability hold a price between $132.53 and $147.67 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

AZNCF Signals & Forecast

The AstraZeneca PLC stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $137.32 and $133.24. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, April 17, 2024, and so far it has fallen -1.36%. Further fall is indicated until a new bottom pivot has been found. AstraZeneca PLC gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The stock had a Golden Star Signal on Thursday, March 07, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Buy
Special Signal Notification

Golden Star

The stock had a Golden Star Signal on Thursday, March 07, 2024 in the short-term chart.

Golden Star Signal is when the short-term moving average, the long-term moving average, and price line meet in a special combination. This combination is very rare and often followed by long and strong gains for the stock in question.

Support, Risk & Stop-loss for AstraZeneca PLC stock

On the downside, the stock finds support just below today's level from accumulated volume at $126.63 and $123.50. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AstraZeneca PLC finds support just below today's level at $126.63. If this is broken, then the next support from accumulated volume will be at $123.50 and $121.80.

This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved $5.04 (3.78%) between high and low. For the last week, the stock has had daily average volatility of 1.84%.

Our recommended stop-loss: $133.43 (-3.48%) (This stock has low daily movements and this gives low risk. There is a sell signal from a pivot top found 1 day ago.)

Trading Expectations (AZNCF) For The Upcoming Trading Day Of Friday 19th

For the upcoming trading day on Friday, 19th we expect AstraZeneca PLC to open at $136.56, and during the day (based on 14 day Average True Range), to move between $134.24 and $142.24, which gives a possible trading interval of +/-$4.00 (+/-2.90%) up or down from last closing price. If AstraZeneca PLC takes out the full calculated possible swing range there will be an estimated 5.79% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $138.88 (0.46%) than the support at $126.63 (8.40%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is AstraZeneca PLC stock A Buy?

AstraZeneca PLC holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

Current score: 0.183 Hold/Accumulate Downgraded

Predicted Opening Price for AstraZeneca PLC of Friday, April 19, 2024

Fair opening price April 19, 2024 Current price
$136.56 ( 1.22%) $138.24

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for AZNCF

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 141.60 2.43 %
R2 139.67 1.04 %
R1 138.49 0.177 %
Current price: 138.24
Support S1 134.63 -2.61 %
S2 133.45 -3.47 %
S3 131.52 -4.86 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 140.15 1.38 %
R1 138.88 0.463 %
Current price 138.24
Support S1 126.63 -8.40%
S2 123.50 -10.66%
S3 121.80 -11.89%

AZNCF Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 09, 2024 Feb 22, 2024 Mar 25, 2024 $1.97 1.48%
2 Feb 21, 2024 Feb 21, 2024 Mar 25, 2024 $1.97 1.48%
3 Jul 29, 2023 Aug 10, 2023 Sep 11, 2023 $0.93 0.685%
4 Feb 23, 2023 Feb 23, 2023 Feb 23, 2023 $1.96 1.46%
5 Aug 11, 2022 Aug 11, 2022 Aug 11, 2022 $0.93 0.726%

FAQ

What is the symbol for AstraZeneca PLC Stock and on which exchange is it traded?
The symbol for AstraZeneca PLC is AZNCF and it is traded on the PINK (Pink Sheets).

Should I buy or sell AstraZeneca PLC Stock?
AstraZeneca PLC holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Hold/Accumulate candidate.

How to buy AstraZeneca PLC Stock?
AstraZeneca PLC Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AstraZeneca PLC Stock.

What's the current price of AstraZeneca PLC Stock?
As of the end of day on the 2024-04-18, the price of an AstraZeneca PLC (AZNCF) share was $138.24.

What is the 52-week high and low for AstraZeneca PLC Stock?
The 52-week high for AstraZeneca PLC Stock is $153.10 and the 52-week low is $118.16.

What is the market capitalization of AstraZeneca PLC Stock?
As of the 2024-04-18, the market capitalization of AstraZeneca PLC is 214.304B.
Click to get the best stock tips daily for free!

About AstraZeneca PLC

AstraZeneca PLC AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, Byetta, Crestor, Evrenzo, Farxiga/Forxiga, Komboglyze/Kombiglyze XR, Lokelma, Onglyza, Qtern, and Xigduo/... AZNCF Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT